WORLD-SMART-ENERGY-WEEK
10.2.2016 02:36:25 CET | Business Wire | Press release
Reed Exhibitions Japan will be holding the 12th installment of Japan's largest show for smart and renewable energy - World Smart Energy Week 2016 next month from March 2-4 at Tokyo Big Sight .
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160209006897/en/
Best Platform for Smart & Renewable Energy
Business
Composed of 9
exhibitions
(PV EXPO, PV SYSTEM EXPO, FC
EXPO, BATTERY JAPAN, WIND EXPO, INT'L SMART GRID EXPO,ENERGY MARKET
LIBERALISATION EXPO, ECO HOUSE & ECO BUILDING EXPO and INT'L BIOMASS
EXPO)
and 227 conference sessions
, this
comprehensive business event is expected to bring together 80,000
professionals
and 21,000 conference attendees
from
across Japan and the world.
The show will commence with a ribbon-cutting ceremony inviting over 45
renowned experts from Japan and overseas as dignitaries,
followed
by the World Smart Energy Week Keynote Session
led
by the Ministry of Economy, Trade and Industry (METI)
to
discuss"Current Situation and Issues in Renewable Energy & Energy
Conservation Policies"
and the U.S.
Department of Energy
to hold a talk on "Clean
Energy Revolution Now: Innovating to Accelerate a Low Carbon Future".
Details
of all the Keynotes and Technical sessions can be found in the Conference
Program
.
At the exhibitions a total of 1,430
exhibitors will be showcasing the latest products, technologies and
solutions from various areas of smart and renewable energy business.
Electricity Retail Business on the Rise
There
will be a big focus on the exhibits related to electricity retail
business with the deregulation of the energy market starting April this
year. ENERGY
MARKET LIBERALISATION EXPO
will gather various tools,
applications and services to promote sales for both existing and
new-comers to the electricity retail business. The latest business
strategies of the major gas, electric companies, consultation firms,
new-comers and players from overseas will be shared at the conference
.
At
the ENERGY
MARKET LIBERALISATION EXPO Keynote Session
the key players
of both Eastern and Western Japan - Tokyo Gas
and The
Kansai Electric Power
will be sharing their thoughts.
Growth of Biomass Power Generation
A
major highlight this year will be the launch of INT'L
BIOMASS EXPO
.
The biomass power generation market in
Japan is expected to grow and the latest pelletising technologies,
logistic services, fuel products and other related services to support
the business will be on show for local governments, plants and
institutions to explore and compare. The leaders from the field will
discuss visions for the development of the business at the INT'L
BIOMASS EXPO Keynote Session.
Solar Business Looking Bright
After
the expansion of PV cell and module installations influenced by the
generous Feed-In-Tariff, the business for solar power in Japan is now
shifting towards innovative technologies and solutions such as efficient
manufacturing processes and cost reduction. Such products and
technologies will be highlighted at PV
EXPO
as well as cells and modules of leading firms from both
Japan and abroad. Japanese firms such as PANASONIC,
SHARP, XSOL,
will be showcasing their "Total Energy
Solutions". Major firms from overseas will also continue to exhibit such
as TRINA SOLAR, YINGLI GREEN ENERGY, CANADIAN SOLAR, HANWHA Q
CELLS, JINKO SOLAR, JA SOLAR.
Operation and
Maintenance for PV systems will be a major theme at PV
SYSTEM EXPO
and the update of the latest trends and outlook
of the business will be discussed at the PV
EXPO Keynote Session
by METI, PANASONIC
and
the U.S. Department of Energy.
Growth Returns to Japan's Wind Energy
Increasing
number of wind farm projects in Japan which have passed the 3-year
environment assessment are now ready for business. As cabling and
infrastructure between the capital and the northern region of Japan have
also been installed, potential for wind energy is expected to grow.
Various wind turbines, components, devices and O&M related services will
be exhibited at WIND
EXPO
to aid the expansion of the business. Being the largest
wind energy show in Japan, it will be the perfect venue to negotiate and
network with key players of the business. Future perspectives of the
business will be shared by ENERCON, SENVION, GOLDWIND SCIENCE &
TECHNOLOGY,
and GAMESA
at the
WIND
EXPO Special Session
.
Strategies and prospects
will also be discussed by major players in Japan - METI,
Municipal National Council for Wind Power Promotion, Marubeni Corp.
and MHI
Vestas Offshore Wind
at the
WIND
EXPO Keynote Session
.
Advancing Battery Needs and Technologies
With
the advancements of applications for electric vehicles, drones and
robots, the R&D for next-generation batteries are accelerating. The
latest systems for such batteries and capacitors will be highlighted at BATTERY
JAPAN
.
A new featured exhibit zone for "Battery
Management Systems (BMS)
" will also be launched this year where
BMS for the enhancement of safety, longer life and power efficiency of
batteries will be showcased. As the world's largest renewable battery
show, BATTERY JAPAN will be the best platform to seek the latest
technologies and trends from experts across Japan and the world. Topics
to be featured at the exhibition and the conference
will
be LIB, capacitors, electric vehicles, stationary battery and security
measures. At the BATTERY
JAPAN Keynote Session
"The latest
trends of EV and battery storage technologies towards a low carbon
society
" will be discussed by NISSAN MOTORS, LG
CHEM
and TESLA MOTORS JAPAN
.
Hydrogen Society Infrastructure
For
the ongoing commercialisation of Fuel Cell Electric Vehicles (FCEVs) and
development of its infrastructure, hydrogen stations, storage tanks,
sensing devices, dispensers and component technologies will be
highlighted at FC
EXPO
.
The latest FCEV models from Japan such as Toyota
's MIRAI
will
be available for test drive sessions arranged by THE RESEARCH
ASSOCIATION OF HYDROGEN SUPPLY/UTILIZATION TECHNOLOGY (HySUT).
Being
the largest show of its kind in the world, the show will also feature
the latest and high quality materials, components, devices and
technologies for hydrogen and fuel cells. To share the strategies and
prospects towards a hydrogen society, METI, U.S. DEPARTMENT
OF ENERGY, HONDA MOTORS
and KAWASAKI HEAVY INDUSTRIES
will
be holding the FC
EXPO Keynote Session.
IoT technologies in Smart Communities
As
IoT technologies advance, the latest ICT services, sensor technologies
for wireless networks for Home Energy Management Systems (HEMS) and
Building Management Systems (BEMS) will be major highlights at
INT'L
SMART GRID EXPO
. Major players in the field such as TOSHIBA,
MITSUBISHI ELECTRIC, MITSUBISHI HEAVY INDUSTRIES
and FUJI
ELECTRIC
will be exhibiting their latest technologies and
solutions. At the conference
,
TOKYO
ELECTRIC POWER, MITSUBISHI ELECTRIC, SUMITOMO ELECTRIC INDUSTRIES,
TOSHIBA
and HITACHI
will be updating the
visions of a smart grid society, latest technologies for a stable power
system and developments of smart cities in Japan.
The latest
quality materials and technologies for smart homes and buildings will be
showcased at the concurrently held ECO
HOUSE & ECO BUILDING EXPO
.
For further details of
the exhibitors and exhibits, browse the Exhibitor
Directory
.
Visit with a Free Exhibition Ticket
World
Smart Energy Week 2016 will be open to all smart and renewable energy
related professionals. Exhibition Tickets can be obtained free by online
registration
.
Visiting tips and show
highlights can be found in the Visitor's
Guide
.
For further details visit the
official show websites
or
contact Show Management directly: visitor-eng.wsew@reedexpo.co.jp
.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160209006897/en/
Contact:
World Smart Energy Week Show Management
Reed Exhibitions
Japan Ltd.
Ena Masui, +81-3-3349-8519
pr-eng.wsew@reedexpo.co.jp
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
